Table 2.
RSS | TIRADS 2 or Very Low Risk |
TIRADS 3 or Low Risk |
TIRADS 4 or Intermediate Risk |
TIRADS 5 or High Risk |
Small Nodules < 10 mm |
---|---|---|---|---|---|
Chilean TIRADS |
No FNA or follow-up | FNA (no cut-off) or follow-up | FNA (no cut-off) |
FNA (no cut-off) |
FNA if >3–4 mm and feasible |
Kwak-TIRADS | No FNA | No FNA | TIRADS 4a: ≥25 mm TIRADS 4B: 15 mm |
TIRADS 4 C and 5: ≥10 mm | No FNA |
BTA | No FNA | All nodules | All nodules | All nodules | - |
AACE | No FNA | ≥20 mm and growing lesion or risk factors |
≥20 mm | ≥10 mm | <5 mm no FNA 5–10 mm FNA if clinical or US risk factors or PP |
ATA | ≥20 mm or observation |
≥15 mm | ≥10 mm | ≥10 mm | 5–10 mm FNA if clinical or US risk factors or PP |
K-TIRADS | ≥20 mm | ≥15 mm | ≥10 mm | ≥10 mm | ≥5 mm selective cases |
EU-TIRADS | No FNA | >20 mm | >15 mm | >10 mm | FNA or active surveillance, PP |
ACR-TIRADS | No FNA | ≥25 mm | ≥15 mm | ≥10 mm | No FNA |
C-TIRADS | No FNA | No FNA | ≥15 mm | ≥10 mm | US risk factors |
Note: PP = patient’s preference.